Clinical Trials Browser

Phase 1 × Advanced Cancer × nimotuzumab × Clear all

NCT03554889 2018-06-13

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Phase 1 Unknown

Advanced Cancer